Chronic News and Research

RSS

Positive interim data from Innate MIS416 Phase 1/2 clinical trial for chronic progressive MS

Innate Immunotherapeutics today announced positive interim data from the company's Phase 1/2 clinical trial of MIS416 in patients with chronic progressive multiple sclerosis (MS).

18 Jun 2012

movin' mania, a community wide effort to address childhood obesity

Bon Secours Virginia Health System has launched movin' mania, a community wide effort to address childhood obesity, the leading health concern for children today. The health system gathered community partners and hundreds of area school children for a kickoff rally Thursday at the Science Museum of Virginia.

18 Jun 2012

U.S., India can work together to fight NCDs

"Secretary Clinton's inspiring piece on how the interests of the U.S. and India are aligned on issue after issue compelled me to articulate one more way in which the world's two biggest democracies could pave the way for international co-operation.

18 Jun 2012

Multi-year initiative to help people live longer and better

With 10,000 Americans turning 65 every day - and according to new research released today, a majority of them expect to live to nearly 90 - the celebration of older Americans is a developing trend, and more people are aspiring to live longer and better than ever before.

18 Jun 2012

Updated data from ARIAD’s ponatinib pivotal trial on CML or Ph+ ALL

ARIAD Pharmaceuticals, Inc. today announced updated clinical data from the pivotal PACE trial of its investigational pan-BCR-ABL inhibitor, ponatinib, in patients with chronic myeloid leukaemia (CML) or Philadelphia-positive acute lymphoblastic leukaemia (Ph+ ALL), who are resistant or intolerant to dasatinib or nilotinib or who have the T315I mutation.

18 Jun 2012

Updated results from two clinical trials of Bruton's ibrutinib for CLL/SLL

Pharmacyclics, Inc announced today at the 17th Congress of European Hematology Association updated results from two clinical trials of Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib (PCI-32765), for the treatment of patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

18 Jun 2012

Simple, inexpensive method for preventing type 2 diabetes

A simple, inexpensive method for preventing type 2 diabetes that relies on calling people and educating them on the sort of lifestyle changes they could make to avoid developing the disease has proven effective in a study conducted by researchers at the University of California, San Francisco (UCSF) and the City of Berkeley Department of Public Health.

16 Jun 2012

Insurers, providers announce partnerships in Wash., Pa. and Minn.

Group Health Cooperative and Tacoma-based Franciscan Health System have signed a five-year contract aimed at reducing costs and providing a more seamless experience for patients. Since 1996, Group Health has sent South Sound patients needing hospital care to Franciscan facilities, primarily St. Joseph Medical Center in Tacoma.

16 Jun 2012

Research roundup: Best health care for homeless, new business model for pharma

The cost and coordination of health care for homeless individuals can be a challenge for states. But as this brief describes, establishing supportive housing - which provides social services, usually on site - "can help improve health, increase survival rates, foster mental health recovery, and reduce alcohol and drug use."

16 Jun 2012

CMS awards nearly $18 million to spread collaborative care model for managing depression

The Centers for Medicare and Medicaid Services (CMS) has awarded almost $18 million to a local and national collaboration of partner organizations with the Institute for Clinical Systems Improvement (ICSI) as lead organization.

16 Jun 2012

Latest allergy research presented at EAACI Congress 2012

Ground-breaking research results about stress during pregnancy and changes in pollen potency across Europe will be presented - among other novel research - at the world's leading congress on allergy and immunology - the EAACI Congress 2012 - that will open tomorrow in Geneva, Switzerland.

16 Jun 2012

Otsuka, Bristol-Myers Squibb announce six-year data from SPRYCEL Phase 3 trial on CP-CML

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Europe Ltd., today announced six-year follow-up results from a Phase 3 randomised, open-label, dose-optimisation study of SPRYCEL (dasatinib) in Philadelphia chromosome-positive (Ph+) chronic-phase chronic myeloid leukaemia (CP-CML) adult patients resistant or intolerant to Glivec (imatinib).

16 Jun 2012

New model can eradicate childhood obesity in private sector

Sanofi US and the Alliance for a Healthier Generation, a non-profit organization founded by the American Heart Association and the William J. Clinton Foundation, today announced a new model for the private sector to combat childhood obesity.

16 Jun 2012

Study calls for overhaul in health care practices for elderly prisoners

Soaring numbers of older, sicker prisoners are causing an unprecedented health care challenge for the nation's criminal justice system, according to a new UCSF report.

15 Jun 2012

Better care for dual-eligible Medicare-Medicaid patients could reduce hospitalization rates

Providing better care for dual-eligible Medicare-Medicaid patients could significantly reduce hospitalization rates for this population, saving taxpayers between $625 million and $1.9 billion per year, according to a new study by researchers at RTI International and Florida Atlantic University.

15 Jun 2012

Advances in robotic spine surgery

1. Please could you give a brief outline of robotic spine surgery and its recent history? Robotic spine surgery is very new, less than 10 years old. There are only 10 hospitals in the US offering it and we are the second hospital in California to offer this technology.

15 Jun 2012

Electronic health records inspire Mostashari, researchers, Olympians

CQ HealthBeat interviews the head of the government's IT effort while other news coverage focuses on a new report detailing the promise of electronic health monitoring.

15 Jun 2012

Longer looks: Battling HIV in Washington; Adderall use among U.S. high schoolers

On a recent day not far from Capitol Hill and the White House, about a dozen HIV outreach workers toting bright yellow duffle bags stuffed with condoms and prevention information stood outside of the Anacostia Metro station. ... After a couple of hours, they had handed out hundreds of packs of condoms -- and had persuaded 21 people to take an HIV test with an oral swab in a Chevy van parked nearby. "You have to know your status, man. I'd rather be safe than sorry," said Alvern Harris, 25, as he waited for his results.

15 Jun 2012

Homeless people with CKD experience higher rates of premature death and kidney failure

Among patients with moderate to advanced chronic kidney disease (CKD), homeless people experience higher rates of premature death and kidney failure, and they use emergency services much more often than impoverished peers with stable housing, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology.

15 Jun 2012

Antioxidant rhSOD reduces risk of blindness in extremely low gestational age newborns

Retinopathy of prematurity (ROP) is the second most common cause of childhood blindness in the United States, occurring in half of premature infants born earlier than or at 28 weeks gestational age. The condition is caused by abnormal blood vessel development in the retina of the eye. ROP risk increases with decreasing gestational age.

15 Jun 2012